Faculty of Medicine, Department of Emergency Medicine, Mersin University, Mersin, Turkey.
Faculty of Medicine, Department of Cardiology, Mersin University, Mersin, Turkey.
Cardiovasc Toxicol. 2021 Jan;21(1):49-58. doi: 10.1007/s12012-020-09594-2. Epub 2020 Sep 7.
The neurohumoral and inflammatory pathways proposed for the development and progression of heart failure (HF) remain up-to-date. We aimed to investigate the effect of emergency department (ED) visits and inflammatory markers on mortality in HF patients. Two-hundred patients with stable chronic HF followed by the cardiology clinic were included in this study. The patients were divided into two groups as patients who had visited the ED due to worsening HF symptoms within the last 6 months (ED visit Group) and who had not (No ED visit Group). The demographical properties, clinical characteristics, and laboratory values including inflammatory markers of the patients were recorded. During the follow-up period, 38 patients (19%) died. In HF patients with previous ED visits, the mortality risk was 2.091 times higher (relative risk, RR). It was identified that the HF patients who died during the follow-up had higher initial NLR (p = 0.004), IG% (p = 0.029), hs-CRP (p = 0.001), and NT-proBNP (p = 0.004) values. It was observed that the area under the curve (AUC) values, NLR (AUC: 0.705, p < 0.001), IG% (AUC: 0.652, p = 0.003), and hs-CRP (AUC: 0.732, p < 0.001) were very strong predictors of the 1-year mortality. According to the cut-off points, the mortality risk (RR) was 3.39 times higher in patients with NLR > 3.7 (95% CI 1.783-6.444), 2.39 times higher when IG% > 0.4 (95% CI 1.16-4.957), and 4,2 times higher when hs-CRP > 9.9 mg/dl (95% CI 2.16-8.16) (p < 0.05). The patients with chronic stable HF who visited the ED within the last six months and having increased NLR, IG%, and CRP levels among inflammatory markers were associated with a higher mortality risk at 1 year.
神经体液和炎症途径被认为与心力衰竭(HF)的发生和发展有关。本研究旨在探讨急诊科(ED)就诊和炎症标志物对 HF 患者死亡率的影响。
这项研究纳入了 200 例在心脏病门诊就诊的稳定型慢性 HF 患者。根据患者在过去 6 个月内因 HF 症状恶化而就诊于 ED 的情况,将患者分为两组:ED 就诊组和非 ED 就诊组。记录患者的人口统计学特征、临床特征和实验室值,包括炎症标志物。
在随访期间,有 38 例(19%)患者死亡。在有 ED 就诊史的 HF 患者中,死亡风险是 2.091 倍(相对风险)。研究还发现,在随访期间死亡的 HF 患者的初始 NLR(p=0.004)、IG%(p=0.029)、hs-CRP(p=0.001)和 NT-proBNP(p=0.004)值更高。
还观察到,NLR(AUC:0.705,p<0.001)、IG%(AUC:0.652,p=0.003)和 hs-CRP(AUC:0.732,p<0.001)的 AUC 值是 1 年死亡率的非常强的预测因素。根据截断值,NLR>3.7(95%CI 1.783-6.444)的患者死亡风险(RR)增加 3.39 倍,IG%>0.4(95%CI 1.16-4.957)的患者死亡风险增加 2.39 倍,hs-CRP>9.9mg/dl(95%CI 2.16-8.16)的患者死亡风险增加 4.2 倍(p<0.05)。
在过去 6 个月内因 HF 症状恶化而就诊于 ED 的慢性稳定型 HF 患者,其 NLR、IG%和 CRP 等炎症标志物水平升高,与 1 年时的高死亡率相关。